| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |